| - GRCh37:
- Chr17:7577537-7577538
- GRCh38:
- Chr17:7674219-7674220
| TP53 | | Li-Fraumeni syndrome 1 | Pathogenic (Mar 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579368-7579369
- GRCh38:
- Chr17:7676050-7676051
| TP53 | Y107fs, Y68fs | Li-Fraumeni syndrome 1 | Likely pathogenic (Apr 29, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579396
- GRCh38:
- Chr17:7676078
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Apr 12, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577497
- GRCh38:
- Chr17:7674179
| TP53 | | Li-Fraumeni syndrome 1 | Likely pathogenic (Jan 12, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572932-7572933
- GRCh38:
- Chr17:7669614-7669615
| TP53 | D234fs, D261fs, D354fs, D393fs | Li-Fraumeni syndrome 1 | Uncertain significance (Jan 31, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579601
- GRCh38:
- Chr17:7676283
| TP53 | | Li-Fraumeni syndrome 1 | not provided | no assertion provided |
| - GRCh37:
- Chr17:7578402
- GRCh38:
- Chr17:7675084
| TP53 | C17*, C44*, C137*, C176* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 | Pathogenic (Jul 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577494
- GRCh38:
- Chr17:7674176
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578531-7578532
- GRCh38:
- Chr17:7675213-7675214
| TP53 | M133fs, M1fs, M94fs | Li-Fraumeni syndrome 1 | Likely pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579533
- GRCh38:
- Chr17:7676215
| TP53 | Q52*, Q13* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578204
- GRCh38:
- Chr17:7674886
| TP53 | S176fs, S215fs, S56fs, S83fs | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577507
- GRCh38:
- Chr17:7674189
| TP53 | E99D, E126D, E219D, E258D | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Uncertain significance (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579840-7579841
- GRCh38:
- Chr17:7676522-7676523
| TP53 | L25fs | Adrenocortical carcinoma, hereditary, Basal cell carcinoma, susceptibility to, 7, Colorectal cancer, Li-Fraumeni syndrome 1, Choroid plexus papilloma, Bone marrow failure syndrome 5, Glioma susceptibility 1 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578514
- GRCh38:
- Chr17:7675196
| TP53 | K100T, K139T, K7T | not specified, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578553-7578565
- GRCh38:
- Chr17:7675235-7675247
| TP53 | | Li-Fraumeni syndrome 1 | Likely pathogenic (Feb 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578129
- GRCh38:
- Chr17:7674811
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, not provided, Li-Fraumeni syndrome | Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579352
- GRCh38:
- Chr17:7676034
| TP53 | G112D, G73D | Li-Fraumeni syndrome 1, not provided, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577533
- GRCh38:
- Chr17:7674215
| TP53 | P118S, P211S, P250S, P91S | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, not provided, Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577594
- GRCh38:
- Chr17:7674276
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, not provided | Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576501
- GRCh38:
- Chr17:7673183
| TP53 | | Li-Fraumeni syndrome 1, Hereditary breast ovarian cancer syndrome, not provided, Hereditary cancer-predisposing syndrome | Benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577407
- GRCh38:
- Chr17:7674089
| TP53 | | Li-Fraumeni syndrome 1, Hereditary breast ovarian cancer syndrome, not provided, Hereditary cancer-predisposing syndrome | Benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577427
- GRCh38:
- Chr17:7674109
| TP53 | | not provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Hereditary breast ovarian cancer syndrome | Benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577085-7577111
- GRCh38:
- Chr17:7673767-7673793
| TP53 | | Li-Fraumeni syndrome 1 | Likely pathogenic (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578129
- GRCh38:
- Chr17:7674811
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, not specified, not provided | Benign/Likely benign (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578291
- GRCh38:
- Chr17:7674973
| TP53 | | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Pathogenic (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579867
- GRCh38:
- Chr17:7676549
| TP53 | Q16K | Li-Fraumeni syndrome 1 | Uncertain significance (Jun 16, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7577072
- GRCh38:
- Chr17:7673754
| TP53 | L130P, L157P, L250P, L289P | Li-Fraumeni syndrome 1 | Likely benign (Jun 16, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7578399
- GRCh38:
- Chr17:7675081
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7571487-7571488
- GRCh38:
- Chr17:7668169-7668170
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1 | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577582
- GRCh38:
- Chr17:7674264
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579498
- GRCh38:
- Chr17:7676180
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574018
- GRCh38:
- Chr17:7670700
| TP53 | R178S, R205S, R298S, R337S | Li-Fraumeni syndrome 1 | Uncertain significance (Jun 3, 2021) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7577113
- GRCh38:
- Chr17:7673795
| TP53 | C116*, C143*, C236*, C275* | Li-Fraumeni syndrome 1 | Pathogenic (Apr 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579922
- GRCh38:
- Chr17:7676604
| TP53 | | not provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577046
- GRCh38:
- Chr17:7673728
| TP53 | E139fs, E166fs, E259fs, E298fs | not provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7572980
- GRCh38:
- Chr17:7669662
| TP53 | T218P, T245P, T338P, T377P | Li-Fraumeni syndrome 1 | Uncertain significance (Mar 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7578443-7578448
- GRCh38:
- Chr17:7675125-7675130
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Mar 14, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7577604
- GRCh38:
- Chr17:7674286
| TP53 | G187A, G94A, G67A, G226A | Li-Fraumeni syndrome, Adrenocortical carcinoma, hereditary, Familial cancer of breast, Glioma susceptibility 1, Li-Fraumeni syndrome 1, Nasopharyngeal carcinoma, Carcinoma of pancreas, Choroid plexus papilloma, Bone osteosarcoma, Basal cell carcinoma, susceptibility to, 7, Hepatocellular carcinomaColorectal cancer, Bone marrow failure syndrome 5, ...see more | Uncertain significance (Nov 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578475-7578477
- GRCh38:
- Chr17:7675157-7675159
| TP53 | P114del, P153del, P21del | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576929-7576940
- GRCh38:
- Chr17:7673611-7673622
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Conflicting interpretations of pathogenicity (Sep 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7578169-7578171
- GRCh38:
- Chr17:7674851-7674853
| TP53 | | Hereditary cancer-predisposing syndrome, Breast and/or ovarian cancer, Li-Fraumeni syndrome 1
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579908
- GRCh38:
- Chr17:7676590
| TP53 | E2G | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577597
- GRCh38:
- Chr17:7674279
| TP53 | D189E, D228E, D69E, D96E | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7577047
- GRCh38:
- Chr17:7673729
| TP53 | H258Q, H297Q, H138Q, H165Q | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577100
- GRCh38:
- Chr17:7673782
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Likely benign (Oct 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578273
- GRCh38:
- Chr17:7674955
| TP53 | Q60H, Q33H, Q153H, Q192H | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577589
- GRCh38:
- Chr17:7674271
| TP53 | T99S, T72S, T192S, T231S | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577169
- GRCh38:
- Chr17:7673851
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Likely benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578568
- GRCh38:
- Chr17:7675250
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578423
- GRCh38:
- Chr17:7675105
| TP53 | M130I, M169I, M10I, M37I | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573007
- GRCh38:
- Chr17:7669689
| TP53 | H329N, H209N, H368N, H236N | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579468
- GRCh38:
- Chr17:7676150
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7572783
- GRCh38:
- Chr17:7669465
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7590789
- GRCh38:
- Chr17:7687471
| LOC126862483, TP53, WRAP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572759
- GRCh38:
- Chr17:7669441
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572599
- GRCh38:
- Chr17:7669281
| TP53 | | Li-Fraumeni syndrome 1 | Benign (Mar 6, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572570
- GRCh38:
- Chr17:7669252
| TP53 | | Li-Fraumeni syndrome 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572518
- GRCh38:
- Chr17:7669200
| TP53 | | Li-Fraumeni syndrome 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7579934
- GRCh38:
- Chr17:7676616
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572167
- GRCh38:
- Chr17:7668849
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572166
- GRCh38:
- Chr17:7668848
| TP53 | | Li-Fraumeni syndrome 1 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7571795
- GRCh38:
- Chr17:7668477
| TP53 | | Li-Fraumeni syndrome 1, not provided | Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7577161
- GRCh38:
- Chr17:7673843
| TP53 | | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Uncertain significance (Aug 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579906
- GRCh38:
- Chr17:7676588
| TP53 | E3K | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7579710
- GRCh38:
- Chr17:7676392
| TP53 | N29T | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Uncertain significance (May 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577018-7577019
- GRCh38:
- Chr17:7673700-7673701
| TP53 | | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577112
- GRCh38:
- Chr17:7673794
| TP53 | A117T, A276T, A144T, A237T | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577137
- GRCh38:
- Chr17:7673819
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577512
- GRCh38:
- Chr17:7674194
| TP53 | L218V, L98V, L257V, L125V | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578201
- GRCh38:
- Chr17:7674883
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Squamous cell carcinoma of the head and neck | Benign/Likely benign (Jul 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578206-7578207
- GRCh38:
- Chr17:7674888-7674889
| TP53 | H214fs, H55fs, H82fs, H175fs | not provided, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Pathogenic (Apr 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578212
- GRCh38:
- Chr17:7674894
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578216
- GRCh38:
- Chr17:7674898
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578227
- GRCh38:
- Chr17:7674909
| TP53 | D208H, D49H, D169H, D76H | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579854
- GRCh38:
- Chr17:7676536
| TP53 | S20L | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578259
- GRCh38:
- Chr17:7674941
| TP53 | V197G, V38G, V158G, V65G | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Sep 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578286
- GRCh38:
- Chr17:7674968
| TP53 | L149fs, L56fs, L188fs, L29fs | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578388
- GRCh38:
- Chr17:7675070
| TP53 | R181P, R22P, R142P, R49P | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578399
- GRCh38:
- Chr17:7675081
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Likely benign (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578420
- GRCh38:
- Chr17:7675102
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578475
- GRCh38:
- Chr17:7675157
| TP53 | P152R, P20R, P113R | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Pathogenic/Likely pathogenic (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578492
- GRCh38:
- Chr17:7675174
| TP53 | W146C, W107C, W14C | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579871
- GRCh38:
- Chr17:7676553
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578504-7578540
- GRCh38:
- Chr17:7675186-7675222
| TP53 | N131fs, M1fs, N92fs | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Familial cancer of breast | Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578547
- GRCh38:
- Chr17:7675229
| TP53 | P128L, P89L | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7578551
- GRCh38:
- Chr17:7675233
| TP53 | S127T, S88T | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7579349
- GRCh38:
- Chr17:7676031
| TP53 | F74S, F113S | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 | Uncertain significance (May 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576855
- GRCh38:
- Chr17:7673537
| TP53 | Q292K, Q172K, Q199K, Q331K | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576900
- GRCh38:
- Chr17:7673582
| TP53 | P277S, P157S, P316S, P184S | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Conflicting interpretations of pathogenicity (Sep 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7576930
- GRCh38:
- Chr17:7673612
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Likely benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579378
- GRCh38:
- Chr17:7676060
| TP53 | Y103*, Y64* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579884
- GRCh38:
- Chr17:7676566
| TP53 | V10G | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7572979
- GRCh38:
- Chr17:7669661
| TP53 | T377I, T218I, T245I, T338I | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7573974
- GRCh38:
- Chr17:7670656
| TP53 | K351N, K219N, K312N, K192N | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574011
- GRCh38:
- Chr17:7670693
| TP53 | E300G, E180G, E207G, E339G | not provided, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579886
- GRCh38:
- Chr17:7676568
| TP53 | S9R | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 | Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7579504
- GRCh38:
- Chr17:7676186
| TP53 | D22E, D61E | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
| Conflicting interpretations of pathogenicity (Apr 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7572932
- GRCh38:
- Chr17:7669614
| TP53 | D234H, D261H, D354H, D393H | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:7579580
- GRCh38:
- Chr17:7676262
| TP53 | P36L | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
| Uncertain significance (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573997
- GRCh38:
- Chr17:7670679
| TP53 | | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Likely benign (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |